Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Desvenlafaxine succinate monohydrate manufacturers

Filters

None products found

desvenlafaxine succinate monohydrate

Tablets, extended release (ER) 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 29 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, FDA
Manufacturer #2655

The company is a pharmaceutical manufacturer engaged in the research, development, production and distribution of a broad portfolio of branded and generic pharmaceutical products across multiple therapeutic areas, operating with state-of-the-art manufacturing facilities and quality systems to produce and supply these pharmaceutical products to healthcare providers and markets in India and internationally.

Manufacturer usually replies in 13 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454

A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.